International Patent: SACITUZUMAB GOVITECAN FORMULATIONS AND METHODS OF MANUFACTURE

GENEVA, Sept. 24 -- GILEAD SCIENCES, INC. filed a patent application (US2025/031778) for “SACITUZUMAB GOVITECAN FORMULATIONS AND METHODS OF MANUFACTURE”. With publication no. WO/2025/251025, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 9/19

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....